IBM (IBM) Tops Q3 EPS by 2c, Affirms Guidance

Go back to IBM (IBM) Tops Q3 EPS by 2c, Affirms Guidance

IBM (IBM) PT Raised to $165 at Citi

October 18, 2017 8:22 AM EDT

Citi raised its price target on IBM (NYSE: IBM) to $165.00 (from $160.00) while maintaining a Neutral rating.

... More

IBM (IBM) PT Raised to $160 at UBS

October 18, 2017 7:06 AM EDT

UBS raised its price target on IBM (NYSE: IBM) to $160.00 (from $152.00) while maintaining a Neutral rating.

Analyst Steven Milunovich believes the business is stabilizing and expects earnings upside in 2019. The analyst remains sidelined noting the shares appear fully valued.

... More

IBM (IBM) Needs A Sustainable Pivot In Business Momentum - Keybanc

October 18, 2017 6:09 AM EDT

KeyBanc maintains Sector Weight on IBM (NYSE: IBM).

Analyst Arvind Ramnani comments "We expect the stock to react positively tomorrow; however, we would need to see a more sustainable pivot in IBM's business momentum to become more constructive on the... More

IBM (IBM) Strategic Imperatives Growth Accelerates - JMP Securities

October 18, 2017 6:07 AM EDT

JMP Securities maintains Market Outperform on IBM (NYSE: IBM) price target of $188.00.

Analyst Greg McDowell comments "We believe one reason the stock was up in the aftermarket is that it was a broad based revenue beat. IBM beat on revenue across all... More

IBM (IBM) Should Build A Base Of Investors At These Higher Levels, Q3 Results Encouraging - Stifel

October 18, 2017 6:03 AM EDT

Stifel maintains Buy on IBM (NYSE: IBM) price target of $182.00.

Analyst David Grossman comments "Given the favorable set-up into 2018 and continued support from the dividend, we would expect the stock to build a base at these higher levels. While one... More

IBM (IBM) PT Raised to $133 at Barclays

October 18, 2017 6:00 AM EDT

Barclays raised its price target on IBM (NYSE: IBM) to $133.00 (from $132.00) while maintaining a Underweight rating.

Analyst Mark Moskowitz says margins remain a concern and advises clients to remain cautious on the stock. The analyst also notes the cloud continue to have a disproportionately... More

IBM (IBM) Revenue Beat Should Support The Stock But No Inflection In Sight Yet - Goldman Sachs

October 18, 2017 5:58 AM EDT

Goldman Sachs maintains Neutral on IBM (NYSE: IBM) price target of $170.00.

Analyst James Schneider says the revenues beat should help support the stock valuation but feels an inflection point is required to drive a re-rating noting the company needs to demonstrate revenue and... More